Evaluation of QTc interval prolongation in patients with advanced clear cell renal cell carcinoma treated with first line sunitinib.
| Publicado en: | Cancer Chemotherapy & Pharmacology Vol. 96; no. 1; pp. 1 - 12 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
9/17/2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |